Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol-Myers Squibb (BMY) Q4 2022 Earnings Call Transcript
07:00pm, Thursday, 02'nd Feb 2023 The Motley Fool
BMY earnings call for the period ending December 31, 2022.
Compared to Estimates, Bristol Myers (BMY) Q4 Earnings: A Look at Key Metrics
05:58pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
While the top- and bottom-line numbers for Bristol Myers (BMY) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics c
Economic Data Deluge
04:04pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
Economic Data Deluge.
Goldilocks Econ Data Presides Over Pre-Market
03:39pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
We haven't thrown around the term "Goldilocks" too much lately, but this morning, the shoe fits.
Pharma earnings: COVID ‘is highly uncertain for this year,' analyst says
02:36pm, Thursday, 02'nd Feb 2023
Pharma Wells Fargo Managing Director Mohit Bansal joins Yahoo Finance Live anchors Rachelle Akuffo and Anjalee Khemlani to discuss pharmaceutical earnings amid COVID uncertainty, the impact of diabeti
Compared to Estimates, Bristol Myers (BMY) Q4 Earnings: A Look at Key Metrics
02:18pm, Thursday, 02'nd Feb 2023
While the top- and bottom-line numbers for Bristol Myers (BMY) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics c
Bristol Myers Squibb (BMY) Q4 Earnings and Revenues Surpass Estimates
01:15pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
Bristol Myers (BMY) delivered earnings and revenue surprises of 6.43% and 2.37%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
There's still too much risk in stock and bond markets. Earn this easy 4.5% return while you wait for stability, says trader who hit 2 big calls in 2022.
12:54pm, Thursday, 02'nd Feb 2023 MarketWatch
In our call of the day, LaDuc says cash is the place to be and that investors are "being paid to wait. They're getting very favorable 4.5% on their sitting cash."
Bristol-Myers Squibb Company (BMY) Q4 2022 Earnings Call Transcript
12:06pm, Thursday, 02'nd Feb 2023
Bristol-Myers Squibb Company (NYSE:BMY ) Q4 2022 Earnings Conference Call February 2, 2023 9:00 AM ET Company Participants Timothy Power - VP & Head, IR Giovanni Caforio - Chairman & CEO David Elkins
Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?
11:34am, Thursday, 02'nd Feb 2023 Benzinga
The index futures point to a mixed opening on Thursday, as tech earnings continue to be encouraging. Meta Platform Inc’s (NASDAQ: META) strong earnings could set the tempo for the market mood as tr
Bristol Myers Squibb (BMY) Q4 Earnings and Revenues Surpass Estimates
09:47am, Thursday, 02'nd Feb 2023
Bristol Myers (BMY) delivered earnings and revenue surprises of 6.43% and 2.37%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Bristol Myers Stock Rises as Revenue Falls on Lower Revlimid Sales but Profit Tops Estimates
07:39am, Thursday, 02'nd Feb 2023
Bristol Myers posts fourth-quarter earnings of $1.82 a share on revenue of $11.4 billion.
Bristol Myers Squibb sees revenue fall in Q4
07:20am, Thursday, 02'nd Feb 2023
Shares of Bristol Myers Squibb Co. BMY, -1.95% gained 0.9% in premarket trading on Thursday after the company announced better-than-expected earnings for the fourth quarter of 2022. Bristol Myers Squi
Drug/Biotech Stocks Q4 Earnings Due on Feb 2: GILD, MRK & Others
03:44pm, Wednesday, 01'st Feb 2023 Zacks Investment Research
Let's look at the four biotech/pharma companies slated to release quarterly results on Feb 2.
